| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10690882 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 477 journal articles in the PubMed database | Email to a friend | | |
| Bone HG, Greenspan SL, McKeever C, et al.
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Endocrinol Metab 2000 Feb; 85(2):720-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Murphy MG, Weiss S, McClung M, et al.
Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Endocrinol Metab 2001 Mar; 86(3):1116-25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Greenspan SL, Emkey RD, Bone HG, et al.
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ann Intern Med 2002 Dec 3; 137(11):875-83.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bell NH, Bilezikian JP, Bone HG, et al.
Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Endocrinol Metab 2002 Jun; 87(6):2792-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bone HG, Downs RW, Tucci JR, et al.
Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Endocrinol Metab 1997 Jan; 82(1):265-74.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Reid IR, Eastell R, Fogelman I, et al.
A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Arch Intern Med 2004 Apr 26; 164(8):871-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lems WF, Lodder MC, Lips P, et al.
Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. [Journal Article]
Osteoporos Int 2006 May; 17(5):716-23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Johnell O, Scheele WH, Lu Y, et al.
Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Endocrinol Metab 2002 Mar; 87(3):985-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Prestwood KM, Gunness M, Muchmore DB, et al.
A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Endocrinol Metab 2000 Jun; 85(6):2197-202.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
